Premium
Response to ‘comparison of “sequential” versus “standard” chemotherapy as re‐induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (aml): results of the uk medical research council aml‐r trial’
Author(s) -
Smith B. Douglas,
Karp Judith,
Burke Philip
Publication year - 2003
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.2003.04395_5.x
Subject(s) - medicine , cytarabine , etoposide , chemotherapy , induction chemotherapy , haematopoiesis , oncology , myeloid leukaemia , minimal residual disease , refractory (planetary science) , leukemia , pharmacology , immunology , stem cell , biology , genetics , astrobiology